Helen W. Boucher
- Applied Microbiology and Biotechnology top 0.05%
- Antibiotic Use and Resistance 21
- Molecular Medicine top 0.02%
- Antibiotic Resistance in Bacteria 20
- Clinical Biochemistry top 0.1%
- Bacterial Identification and Susceptibility Testing 27
- Infectious Diseases top 0.2%
- Antimicrobial Resistance in Staphylococcus 27
- Antifungal resistance and susceptibility 6
- Microbiology top 0.2%
-
- Infective Endocarditis Diagnosis and Management 14
- Pneumonia and Respiratory Infections 8
-
- Antibiotics Pharmacokinetics and Efficacy 14
Helen W. Boucher
80 papers receiving 10.0k citations
Hit Papers
Peers
Comparison fields: 5 of 160
- Applied Microbiology and Biotechnology 1.7k
- Molecular Medicine 3.8k
- Clinical Biochemistry 1.7k
- Infectious Diseases 3.3k
- Microbiology 928
Countries citing papers authored by Helen W. Boucher
This map shows the geographic impact of Helen W. Boucher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen W. Boucher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen W. Boucher more than expected).
Fields of papers citing papers by Helen W. Boucher
This network shows the impact of papers produced by Helen W. Boucher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen W. Boucher. The network helps show where Helen W. Boucher may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Helen W. Boucher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 8 | |
| 8 | 2021 | 18 | |
| 9 | 2018 | 30 | |
| 10 | 2015 | 12 | |
| 11 | 2015 | 58 | |
| 12 | 2014 | 10 | |
| 13 | 10 x '20 Progress--Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of Americabreakdown → | 2013 | 555 |
| 14 | 2011 | 116 | |
| 15 | 2009 | 47 | |
| 16 | Epidemiology of Methicillin‐ResistantStaphylococcus aureusbreakdown → | 2008 | 639 |
| 17 | Outcomes with Daptomycin vs. Standard Therapy for S. aureus Bone and Joint Infections | 2006 | 1 |
| 18 | 2006 | 20 | |
| 19 | 2005 | 65 | |
| 20 | 2001 | 29 |
About Helen W. Boucher
Helen W. Boucher is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Clinical Biochemistry, having authored 89 papers that have together received 10.4k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (27 papers), Bacterial Identification and Susceptibility Testing (27 papers), Antibiotic Use and Resistance (21 papers), Antibiotic Resistance in Bacteria (20 papers), Infective Endocarditis Diagnosis and Management (14 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers), Pneumonia and Respiratory Infections (8 papers) and Antifungal resistance and susceptibility (6 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (1.7k citations), Molecular Medicine (3.8k citations) and Clinical Biochemistry (1.7k citations). Helen W. Boucher has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include John S. Bradley, David N. Gilbert, George H. Talbot, Brad Spellberg, John E. Edwards, Michael Scheld, Louis B. Rice, John Bartlett, G. Ralph Corey and R. Guidos. Their work appears in journals such as New England Journal of Medicine, JAMA and Annals of Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.